Melior Pharmaceuticals Announces New Scientific Advisory Board Member Dr. John Amatruda, an Expert in the Field of Diabetes and Drug Development to Join Board

EXTON, Pa.--(BUSINESS WIRE)--Melior Pharmaceuticals, Inc. announced today that it has appointed Dr. John Amatruda to its Scientific Advisory Board. Dr. Amatruda comes to Melior with over 15 years of experience in academic medicine and 17 years experience in industry.